Akero Therapeutics, Inc

(NASDAQ:AKRO)

Latest On Akero Therapeutics, Inc (AKRO):

Date/Time Type Description Signal Details
2023-05-18 02:59 ESTNewsAkero Therapeutics: A Promising Solution For NASH Patients And InvestorsN/A
2023-05-17 13:48 ESTNewsAkero Therapeutics prices $220M offeringN/A
2023-05-15 20:39 ESTNewsAkero Therapeutics GAAP EPS of -$0.55N/A
2023-05-09 09:17 ESTNewsAkero Therapeutics: Proof Of Concept With EFX, Sets Up Catalyst Opportunities In 2023N/A
2023-05-07 19:00 ESTNewsAkero Therapeutics: Excellent Data, Solid Clinical Potential, No Major Near Term CatalystsN/A
2023-03-30 00:33 ESTNewsAkero plans to begin Phase 3 trial of NASH treatment in H2 after successful FDA meetN/A
2023-03-17 20:34 ESTNewsAkero Therapeutics GAAP EPS of -$0.49 beats by $0.31N/A
2023-02-08 18:19 ESTNewsAkero Therapeutics: NASH Differentiator Attractive, Awaiting Additional Price CatalystsN/A
2023-01-27 18:31 ESTNewsAkero upgraded at Morgan Stanley on NASH prospectsN/A
2022-12-08 21:25 ESTNewsAkero's liver disease drug gets FDA breakthrough therapy tagN/A
2022-11-24 02:08 ESTNewsAkero Therapeutics: What Is Making The Stock TickN/A
2022-11-04 15:25 ESTNewsAkero Therapeutics GAAP EPS of -$0.92 misses by $0.20N/A
2022-10-25 22:18 ESTNewsAkero: Putting Together The Pieces They Let Us SeeN/A
2022-09-19 18:37 ESTNewsAkero Therapeutics announces closing of upsized public offeringN/A
2022-09-19 02:04 ESTNewsAkero Therapeutics: A Promising NASH InnovatorN/A
2022-09-16 05:21 ESTNewsAkero Therapeutics: Outstanding Data In NASHN/A
2022-09-15 11:26 ESTNewsAkero Therapeutics stock slides on pricing upsized ~$200.0M stock offeringN/A
2022-09-14 18:07 ESTNewsAkero Therapeutics' Positive NASH Trial Results And Cash RaiseN/A
2022-09-14 00:37 ESTNewsAkero stock soars 71% as drug improves liver fibrosis, prevents disease worsening in trialN/A
2022-09-14 00:36 ESTNewsAkero adds over 100% rallying peers after NASH successN/A
2022-09-14 00:36 ESTNewsAkero Therapeutics commences underwritten public offering of $175M of sharesN/A
2022-08-04 23:03 ESTNewsAkero Therapeutics GAAP EPS of -$0.77 beats by $0.10N/A
2022-06-16 14:38 ESTNewsPfizer makes $25M equity investment in AkeroN/A
2022-05-06 18:49 ESTNewsAkero Therapeutics GAAP EPS of -$0.74 beats by $0.07N/A
2022-02-25 22:21 ESTNewsAkero Therapeutics GAAP EPS of -$0.93 misses by $0.13N/A
2022-02-09 07:08 ESTNewsAkero finishes enrollment in phase 2b trial of efruxifermin in liver diseaseN/A
2022-01-12 18:10 ESTNewsAkero Therapeutics (AKRO) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-12 18:10 ESTNewsAkero Therapeutics (AKRO) Investor Presentation - SlideshowN/A
2021-11-12 16:26 ESTNewsAkero Therapeutics EPS beats by $0.16N/A
2021-10-20 02:11 ESTNewsAkero nabs Fast Track designation for efruxifermin for NASHN/A
2021-10-12 20:08 ESTNewsWarning: AKRO is at high risk of performing badlyN/A
2021-10-07 04:15 ESTNewsAKRO is at high risk of performing badlyN/A
2021-09-27 12:22 ESTNewsWarning: AKRO has been downgraded to Very BearishN/A
2021-09-23 22:19 ESTNewsAkero: Ticking All The Right Boxes In NASHN/A
2021-09-22 20:56 ESTNewsWarning: AKRO has been downgraded to Very Bearish.N/A
2021-09-10 16:11 ESTNewsAkero initiated with a buy at BofA on underappreciated clinical profileN/A
2021-08-13 08:25 ESTNewsAkero Therapeutics EPS misses by $0.17N/A
2021-07-20 18:14 ESTNewsAkero Therapeutics' efruxifermin meets primary endpoint in mid-stage NASH trialN/A
2021-07-20 18:08 ESTNewsAkero Therapeutics adds Judy Chou to its board of directorsN/A
2021-04-21 13:38 ESTNews89bio could close the valuation gap with Akero by end of 2021: CantorN/A
2021-03-18 12:04 ESTAnalyst RatingThe Analyst Target Price has decreased from $59.5 to $58.75.Neutral
2021-03-17 20:05 ESTFinancialsCompany financials have been released.Neutral
2021-03-17 12:03 ESTEarnings EstimateAn EPS average of -$3.73 is estimated for the 2022 year.Sell
2021-03-17 12:03 ESTEarnings EstimateAn EPS average of -$0.80 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-16 18:57 ESTNewsAkero Therapeutics EPS misses by $0.29N/A
2021-03-01 11:04 ESTAnalyst RatingThe Analyst Target Price has decreased from $60.29 to $59.5.Neutral
2020-12-13 03:07 ESTFinancialsCompany financials have been released.Neutral
2020-12-11 15:05 ESTFinancialsCompany financials have been released.Neutral
2020-11-25 11:09 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 03:04 ESTFinancialsCompany financials have been released.Neutral

About Akero Therapeutics, Inc (AKRO):

Akero Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for serious metabolic diseases. Its lead product candidate is AKR-001, which is in Phase IIa clinical trial for the treatment of nonalcoholic steatohepatitis disease.The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was founded in 2017 and is headquartered in South San Francisco, California.

AKRO Quotes by TradingView

See Advanced Chart

General

  • Name Akero Therapeutics, Inc
  • Symbol AKRO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 13
  • Fiscal Year EndDecember
  • IPO Date2019-06-20
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.akerotx.com
View More

Valuation

  • Trailing PE 8.18
  • Price/Book (Most Recent Quarter) 4.38
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$3.88
  • Next Year EPS Estimate -$4.26
  • Next Quarter EPS Estimate -$0.55
  • Return on Assets -18%
  • Return on Equity -30%
  • Earnings Per Share -$91.75
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 1.11 billion
  • Analyst Target Price $58.75
  • Book Value Per Share $8.25
View More

Share Statistics

  • Shares Outstanding 34.77 million
  • Shares Float 17.06 million
  • % Held by Insiders 840%
  • % Held by Institutions 93.8%
  • Shares Short 2.23 million
  • Shares Short Prior Month 2.13 million
  • Short Ratio 9.66
  • Short % of Float 12%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • 52 Week High $41.16
  • 52 Week Low $15.02
  • 50 Day Moving Average 31.18
  • 200 Day Moving Average 29.64
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Akero Therapeutics, Inc (AKRO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Akero Therapeutics, Inc (AKRO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-16$N/A-$0.86-$0.59-45.76%
2020-09-302020-11-12$N/A-$0.63-$0.676.11%
2020-06-302020-08-12$N/A-$0.57-$0.627.72%
2020-03-312020-05-13$N/A-$0.42-$0.6131.15%
2019-12-312020-03-16$N/A-$0.55-$0.585.97%
2019-09-302019-11-12$N/A-$0.56-$0.43-30.69%
2019-06-302019-08-12$N/A-$0.26-$0.3628.51%

Akero Therapeutics, Inc (AKRO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Research Development 25.71 million 17.38 million 13.04 million 8.79 million 13.14 million
Income Before Tax -29.71 million -21.4 million -16.21 million -11.89 million -15.61 million
Selling General Administrative 4.07 million 4.16 million 3.42 million 3.59 million 3.08 million
Gross Profit N/A N/A N/A N/A N/A
Ebit -29.77 million -21.54 million -16.45 million -12.38 million -16.22 million
Operating Income -29.78 million -21.54 million -16.45 million -12.38 million -16.22 million
Income Tax Expense N/A N/A N/A N/A N/A
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net 72000 N/A N/A N/A 610000
Net Income From Continuing Operations -29.71 million -21.4 million -16.21 million -11.89 million -15.61 million
Net Income Applicable to Common Shares -29.71 million -21.4 million -16.21 million N/A -15.61 million
Cash Flow:
Date Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019 Sep 30 2019
Investments -59.84 million 38.47 million -6.28 million N/A N/A
Change to Liabilities 2.1 million 1 million N/A N/A -1.6 million
Total Cash Flow from Investing Activities -59.84 million 38.47 million N/A N/A N/A
Net Borrowings N/A N/A N/A N/A N/A
Total Cash Flow from Financial Activities 202.78 million 100000 164000 N/A -1.61 million
Change to Operating Activities 4.18 million -8.8 million N/A N/A 3.46 million
Change in Cash 129.43 million 15.98 million -17.43 million N/A -14.82 million
Total Cash from Operating Activities -13.51 million -22.58 million -11.32 million N/A -13.21 million
Depreciation N/A N/A N/A N/A N/A
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities 67000 -67000 N/A N/A N/A
Change to Net Income 1.61 million 1.42 million N/A N/A 483000
Capital Expenditures N/A N/A N/A N/A N/A
Balance Sheet:
Date Dec 31 2020 Sep 30 2020 Jun 30 2020 Mar 31 2020 Dec 31 2019
Total Liabailities 14.63 million 13.58 million 10.4 million 8.3 million 9.39 million
Total Stockholder Equity 258.71 million 286.46 million 103.66 million 118.32 million 128.73 million
Other Current Liabilities 13.11 million 126000 146000 126000 9.37 million
Total Assets 273.34 million 300.04 million 114.06 million 126.62 million 138.12 million
Common Stock 258.71 million 4000 3000 N/A 128.73 million
Other Current Assets 2.96 million N/A N/A N/A 1.65 million
Retained Earnings -209.53 million -179.82 million -158.41 million -142.21 million N/A
Other Liabilities N/A N/A 2000 N/A 23000
Other Assets 1.99 million 156000 865000 N/A 69000
Cash 187.24 million 192.68 million 63.25 million 47.25 million 136.4 million
Total Current Liabilities 13.11 million 12.01 million 10.39 million 8.29 million 9.37 million
Other Stockholder Equity N/A 16000 90000 N/A N/A
Property, Plant & Equipment N/A 1.85 million N/A N/A N/A
Total Current Assets 271.35 million 298.03 million 113.19 million 126.22 million 138.05 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets 258.71 million 286.46 million 103.66 million N/A 128.73 million
Short Term Investments 81.15 million 99.19 million 39.59 million 78.04 million N/A
Long Term Debt N/A N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 3.43 million 4.64 million 2.54 million 1.54 million N/A

Akero Therapeutics, Inc (AKRO) Chart:

Akero Therapeutics, Inc (AKRO) News:

Below you will find a list of latest news for Akero Therapeutics, Inc (AKRO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Akero Therapeutics, Inc (AKRO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-08-1512.50CALL0 0319.45TRUE00
2025-08-15150CALL0 3256.31TRUE00
2025-08-1517.50CALL0 0232.74TRUE00
2025-08-15200CALL0 0217.49TRUE00
2025-08-1522.50CALL0 0187.33TRUE00
2025-08-15250CALL0 0179.22TRUE00
2025-08-1527.523.45CALL0 4165.73TRUE00
2025-08-153023.3CALL0 37165.9TRUE00
2025-08-1532.521.16CALL0 2146.22TRUE00
2025-08-153520.5CALL0 71127.88TRUE00
2025-08-1537.50CALL0 3112.54TRUE00
2025-08-154013.47CALL0 621100.99TRUE00
2025-08-1542.512CALL0 23791.7TRUE00
2025-08-15458.6CALL8 85276.15TRUE-2.4-0.22
2025-08-1547.58.63CALL10 256111.15TRUE8.630
2025-08-15505.8CALL2 154883.27TRUE5.80
2025-08-1552.54.5CALL48 34981.82FALSE4.50
2025-08-15553.2CALL2618 407976.67FALSE-1.25-0.28
2025-08-1557.53.59CALL0 14586.13FALSE00
2025-08-15602CALL4 263181.52FALSE-0.74-0.27
2025-08-1562.51.56CALL0 9380.59FALSE00
2025-08-15651CALL45 42378.89FALSE0.72.33
2025-08-15700.5CALL0 438120.61FALSE00
2025-08-15750CALL0 5144.58FALSE00
2025-08-15800.21CALL125 15086.53FALSE0.210
2025-08-15850CALL0 1173.11FALSE00
2025-08-1512.50PUT0 1276.53FALSE00
2025-08-15150PUT0 0447.61FALSE00
2025-08-1517.50PUT0 0396.2FALSE00
2025-08-15200PUT0 0353.13FALSE00
2025-08-1522.50PUT0 0316.02FALSE00
2025-08-15250.3PUT0 1283.36FALSE00
2025-08-1527.50PUT0 0254.11FALSE00
2025-08-15300PUT0 29202.69FALSE00
2025-08-1532.50PUT0 4203.1FALSE00
2025-08-15350.4PUT0 79108.32FALSE00
2025-08-1537.50.78PUT0 186158.98FALSE00
2025-08-15401.05PUT0 453116.54FALSE00
2025-08-1542.50.6PUT0 45778.87FALSE00
2025-08-15451.2PUT31 339771.62FALSE-0.19-0.14
2025-08-1547.52PUT11 46472.73FALSE20
2025-08-15503PUT45 91272.7FALSE0.70.3
2025-08-1552.54.4PUT1 25075.35TRUE4.40
2025-08-15555.7PUT0 24193.4TRUE00
2025-08-1557.57.1PUT0 7797.9TRUE00
2025-08-15600PUT0 1773.05TRUE00
2025-08-1562.50PUT0 069.45TRUE00
2025-08-156513.1PUT0 15572.84TRUE00
2025-08-15700PUT0 0109.94TRUE00
2025-08-15750PUT0 0125.32TRUE00
2025-08-15800PUT0 0157.2TRUE00
2025-08-15850PUT0 089.44TRUE00
2025-09-19300CALL0 0118.93TRUE00
2025-09-1932.50CALL0 0107.68TRUE00
2025-09-19350CALL0 0103.97TRUE00
2025-09-1937.50CALL0 092.84TRUE00
2025-09-19400CALL0 094.61TRUE00
2025-09-1942.50CALL0 093.79TRUE00
2025-09-19450CALL0 093.95TRUE00
2025-09-1947.50CALL0 089.05TRUE00
2025-09-19508.6CALL9 087.92TRUE8.60
2025-09-1952.50CALL0 090.01FALSE00
2025-09-19556.1CALL44 283.53FALSE-1.4-0.19
2025-09-1957.50CALL0 079.76FALSE00
2025-09-19604CALL0 184.07FALSE00
2025-09-19650CALL0 078.69FALSE00
2025-09-19700CALL0 071.03FALSE00
2025-09-19750CALL0 089.35FALSE00
2025-09-19300PUT0 0150.93FALSE00
2025-09-1932.50PUT0 0134.8FALSE00
2025-09-19350PUT0 0119.8FALSE00
2025-09-1937.50PUT0 0105.69FALSE00
2025-09-19400PUT0 064.1FALSE00
2025-09-1942.50PUT0 061.01FALSE00
2025-09-19452.55PUT0 166.09FALSE00
2025-09-1947.50PUT0 066.39FALSE00
2025-09-19500PUT0 080.26FALSE00
2025-09-1952.50PUT0 083.33TRUE00
2025-09-19550PUT0 081.16TRUE00
2025-09-1957.50PUT0 081.01TRUE00
2025-09-19600PUT0 078.21TRUE00
2025-09-196514.6PUT0 169.33TRUE00
2025-09-19700PUT0 072.02TRUE00
2025-09-19750PUT0 067.9TRUE00
2025-11-21200CALL0 0100.29TRUE00
2025-11-2122.50CALL0 087.37TRUE00
2025-11-21250CALL0 080.57TRUE00
2025-11-2127.50CALL0 075.74TRUE00
2025-11-213023.8CALL1 286.22TRUE23.80
2025-11-2132.50CALL0 080.59TRUE00
2025-11-21350CALL0 080.27TRUE00
2025-11-2137.50CALL0 077.1TRUE00
2025-11-214013.6CALL0 2576.76TRUE00
2025-11-2142.511.7CALL0 1075.15TRUE00
2025-11-214513CALL600 1969.13TRUE130
2025-11-2147.59.5CALL0 5969.2TRUE00
2025-11-21509.5CALL2 25668.15TRUE9.50
2025-11-2152.58CALL0 8262.37FALSE00
2025-11-21558.2CALL1 11074.86FALSE8.20
2025-11-2157.55.65CALL0 1356.63FALSE00
2025-11-21604.8CALL25 3160.6FALSE4.80
2025-11-2162.53.4CALL0 1258.94FALSE00
2025-11-21653.2CALL10 11257.68FALSE3.20
2025-11-21702.9CALL1 155063.83FALSE0.60.26
2025-11-21752CALL1 8562.13FALSE20
2025-11-21801.02CALL0 4852.88FALSE00
2025-11-21200PUT0 0165.71FALSE00
2025-11-2122.50PUT0 0148.43FALSE00
2025-11-21250PUT0 0133.23FALSE00
2025-11-2127.50PUT0 0119.63FALSE00
2025-11-21300PUT0 7107.28FALSE00
2025-11-2132.52.45PUT0 3191.9FALSE00
2025-11-21350PUT0 3086.45FALSE00
2025-11-2137.52.22PUT0 9855.29FALSE00
2025-11-21403.13PUT0 4364.76FALSE00
2025-11-2142.53.7PUT0 1565.07FALSE00
2025-11-21454.2PUT601 3766.38FALSE4.20
2025-11-2147.55.9PUT0 6260.47FALSE00
2025-11-21505.5PUT1 6257.5FALSE5.50
2025-11-2152.56.7PUT1 2856.48TRUE6.70
2025-11-21559.4PUT0 12759.29TRUE00
2025-11-2157.510.8PUT0 5958.94TRUE00
2025-11-216012.3PUT0 13452.46TRUE00
2025-11-2162.511.9PUT0 3652.94TRUE00
2025-11-216514.8PUT0 1052.45TRUE00
2025-11-21700PUT0 051.52TRUE00
2025-11-21750PUT0 044.7TRUE00
2025-11-21800PUT0 076.74TRUE00
2026-01-162.50CALL0 0217.24TRUE00
2026-01-1650CALL0 0194.47TRUE00
2026-01-167.50CALL0 0163.41TRUE00
2026-01-16100CALL0 0145.86TRUE00
2026-01-1612.50CALL0 4120.2TRUE00
2026-01-16150CALL0 1105.47TRUE00
2026-01-1617.50CALL0 6998.15TRUE00
2026-01-16200CALL0 1291.13TRUE00
2026-01-1622.50CALL0 1077.6TRUE00
2026-01-162531CALL0 2675.29TRUE00
2026-01-1627.521.8CALL0 2179.35TRUE00
2026-01-163026.2CALL0 27179.25TRUE00
2026-01-1632.50CALL0 1678.38TRUE00
2026-01-163521.11CALL0 1775.83TRUE00
2026-01-1637.519.38CALL0 6073.2TRUE00
2026-01-164018.7CALL0 5872.4TRUE00
2026-01-1642.516.83CALL0 10571.18TRUE00
2026-01-164514.84CALL0 5670.04TRUE00
2026-01-1647.512.1CALL0 94567.82TRUE00
2026-01-165010.2CALL0 2758.84TRUE00
2026-01-1652.59.25CALL0 1257.15FALSE00
2026-01-16558.2CALL0 7655.81FALSE00
2026-01-1657.58CALL0 2258.2FALSE00
2026-01-16605.95CALL0 4352.02FALSE00
2026-01-1662.56.8CALL0 245.39FALSE00
2026-01-16654.55CALL0 12948.21FALSE00
2026-01-16702.5CALL0 2740.11FALSE00
2026-01-16752.2CALL0 2137.31FALSE00
2026-01-16801.94CALL0 31944.49FALSE00
2026-01-16850CALL0 165.37FALSE00
2026-01-162.50PUT0 0211.54FALSE00
2026-01-1650PUT0 15144.41FALSE00
2026-01-167.50PUT0 0279.34FALSE00
2026-01-16100PUT0 0232.31FALSE00
2026-01-1612.50PUT0 15199.78FALSE00
2026-01-16150PUT0 0175.03FALSE00
2026-01-1617.50PUT0 2155.09FALSE00
2026-01-16200.05PUT1 17060.51FALSE0.050
2026-01-1622.50PUT0 1124.03FALSE00
2026-01-16251.4PUT0 5577.46FALSE00
2026-01-1627.50PUT0 0100.08FALSE00
2026-01-16302.25PUT0 4289.09FALSE00
2026-01-1632.50PUT0 080.37FALSE00
2026-01-16353.1PUT0 2772.51FALSE00
2026-01-1637.52.61PUT0 555.13FALSE00
2026-01-16403.23PUT0 20852.9FALSE00
2026-01-1642.53.88PUT0 3855.04FALSE00
2026-01-16458.4PUT0 1353.49FALSE00
2026-01-1647.55.3PUT0 358.76FALSE00
2026-01-16506.84PUT0 2064.68FALSE00
2026-01-1652.50PUT0 056.34TRUE00
2026-01-16550PUT0 053.14TRUE00
2026-01-1657.50PUT0 051.58TRUE00
2026-01-16600PUT0 047.79TRUE00
2026-01-1662.50PUT0 050.99TRUE00
2026-01-16650PUT0 048.38TRUE00
2026-01-16700PUT0 246.73TRUE00
2026-01-16750PUT0 039.61TRUE00
2026-01-16800PUT0 047.81TRUE00
2026-01-16850PUT0 048.27TRUE00
2026-02-2027.50CALL0 069TRUE00
2026-02-20300CALL0 063.94TRUE00
2026-02-2032.50CALL0 063.26TRUE00
2026-02-20350CALL0 060.88TRUE00
2026-02-2037.50CALL0 062.04TRUE00
2026-02-20400CALL0 060.49TRUE00
2026-02-2042.50CALL0 058.68TRUE00
2026-02-20450CALL0 058.51TRUE00
2026-02-2047.50CALL0 057.18TRUE00
2026-02-20500CALL0 058.24TRUE00
2026-02-2052.50CALL0 055.6FALSE00
2026-02-20559.8CALL0 155.27FALSE00
2026-02-2057.58.5CALL0 251.83FALSE00
2026-02-20600CALL0 050.62FALSE00
2026-02-2062.50CALL0 048.78FALSE00
2026-02-20655.9CALL0 849.59FALSE00
2026-02-20700CALL0 046.16FALSE00
2026-02-20750CALL0 050.5FALSE00
2026-02-20800CALL0 055.49FALSE00
2026-02-2027.50PUT0 092.01FALSE00
2026-02-20300PUT0 083.6FALSE00
2026-02-2032.50PUT0 074.88FALSE00
2026-02-20350PUT0 066.22FALSE00
2026-02-2037.50PUT0 059.94FALSE00
2026-02-20400PUT0 055FALSE00
2026-02-2042.50PUT0 056.22FALSE00
2026-02-20454.9PUT0 856.62FALSE00
2026-02-2047.50PUT0 055.38FALSE00
2026-02-20508.5PUT0 853.45FALSE00
2026-02-2052.50PUT0 054.13TRUE00
2026-02-20550PUT0 054.36TRUE00
2026-02-2057.50PUT0 050.46TRUE00
2026-02-20600PUT0 050.94TRUE00
2026-02-2062.50PUT0 049.16TRUE00
2026-02-20650PUT0 048TRUE00
2026-02-20700PUT0 047.16TRUE00
2026-02-20750PUT0 046.62TRUE00
2026-02-20800PUT0 047.32TRUE00

Latest AKRO Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST22$8.07
Jun 13, 2022 7:59 PM EST11$8.07
Jun 13, 2022 7:59 PM EST14$8.06
Jun 13, 2022 7:59 PM EST10$8.07
Jun 13, 2022 7:59 PM EST47$8.07

Akero Therapeutics, Inc (AKRO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1744659/000110465920079692/0001104659-20-079692-index.htm
2020-05-20UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1744659/000000000020004520/0000000000-20-004520-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-07-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1744659/000090514820000781/0000905148-20-000781-index.htm
2020-09-09SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1744659/000090514820001009/0000905148-20-001009-index.htm
2020-05-15DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1744659/000091205720000169/0000912057-20-000169-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000013/0001012975-20-000013-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000022/0001012975-20-000022-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000029/0001012975-20-000029-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000033/0001012975-20-000033-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000113/0001012975-20-000113-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000115/0001012975-20-000115-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-07-06S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1744659/000104746920003964/0001047469-20-003964-index.htm
2020-07-09424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1744659/000104746920004044/0001047469-20-004044-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000108514620002410/0001085146-20-002410-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920003136/0001104659-20-003136-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920003240/0001104659-20-003240-index.htm
2020-01-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920020276/0001104659-20-020276-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920021077/0001104659-20-021077-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920025042/0001104659-20-025042-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920033412/0001104659-20-033412-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920033680/0001104659-20-033680-index.htm
2020-03-16S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920034183/0001104659-20-034183-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920034208/0001104659-20-034208-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920040850/0001104659-20-040850-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920042006/0001104659-20-042006-index.htm
2020-04-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920051294/0001104659-20-051294-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920060866/0001104659-20-060866-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920066655/0001104659-20-066655-index.htm
2020-06-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920068978/0001104659-20-068978-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069071/0001104659-20-069071-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069072/0001104659-20-069072-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069074/0001104659-20-069074-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069075/0001104659-20-069075-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069077/0001104659-20-069077-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920071713/0001104659-20-071713-index.htm
2020-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920072520/0001104659-20-072520-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920072521/0001104659-20-072521-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920074004/0001104659-20-074004-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920078983/0001104659-20-078983-index.htm
2020-07-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1744659/000110465920079692/0001104659-20-079692-index.htm
2020-07-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1744659/000110465920080872/0001104659-20-080872-index.htm
2020-07-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1744659/000110465920080873/0001104659-20-080873-index.htm
2020-07-078-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920081704/0001104659-20-081704-index.htm
2020-07-07S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1744659/000110465920081820/0001104659-20-081820-index.htm
2020-07-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920082854/0001104659-20-082854-index.htm
2020-07-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920082855/0001104659-20-082855-index.htm
2020-07-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920083453/0001104659-20-083453-index.htm
2020-07-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920083455/0001104659-20-083455-index.htm
2020-08-07RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920092022/0001104659-20-092022-index.htm
2020-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920093910/0001104659-20-093910-index.htm
2020-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920115114/0001104659-20-115114-index.htm
2020-01-15SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1744659/000119312520008095/0001193125-20-008095-index.htm
2020-02-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000119312520028593/0001193125-20-028593-index.htm
2020-07-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1744659/000119312520192675/0001193125-20-192675-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000120919120008127/0001209191-20-008127-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000120919120054791/0001209191-20-054791-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000127417320000103/0001274173-20-000103-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1744659/000155837020002798/0001558370-20-002798-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1744659/000155837020006498/0001558370-20-006498-index.htm
2020-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1744659/000155837020010443/0001558370-20-010443-index.htm
2020-07-07EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1744659/999999999520001708/9999999995-20-001708-index.htm

Akero Therapeutics, Inc (AKRO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Akero Therapeutics, Inc (AKRO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 840%
Institutional Ownership: 9380%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-10-09Kevin BittermanDirectorSell13,000.0028.93376,090.0011,780.00https://www.sec.gov/Archives/edgar/data/1744659/000120919120054791/0001209191-20-054791-index.htm
2020-03-13Jonathan YoungChief Operating OfficerBuy5,035.000.623,096.53177,518.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920034208/0001104659-20-034208-index.htm
2020-03-13Jonathan YoungChief Operating OfficerBuy6,082.000.623,740.43183,600.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920034208/0001104659-20-034208-index.htm
2020-01-10Jonathan YoungChief Operating OfficerBuy17,621.000.6210,836.92211,197.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920003136/0001104659-20-003136-index.htm
2020-03-30G. Walmsley GrahamDirectorBuy2,168.0019.9743,294.962,168.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920042006/0001104659-20-042006-index.htm
2020-03-12Timothy RolphChief Scientific OfficerBuy27,368.000.6116,694.48220,277.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920033412/0001104659-20-033412-index.htm
2020-01-10Jonathan YoungChief Operating OfficerBuy21,286.000.6213,090.89232,483.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920003136/0001104659-20-003136-index.htm
2020-03-12Timothy RolphChief Scientific OfficerBuy22,656.000.6113,820.16242,933.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920033412/0001104659-20-033412-index.htm
2020-07-06Global Strategic Fund II L.P. venBio10% Share HolderSell4,603.0033.83155,721.333,033,552.00https://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-07-02Global Strategic Fund II L.P. venBio10% Share HolderSell3,800.0033.63127,805.403,038,155.00https://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-07-01Global Strategic Fund II L.P. venBio10% Share HolderSell108,064.0034.453,723,010.123,041,955.00https://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-01-21Versant Venture Capital VI, L.P.10% Share HolderSell17,849.0022.39399,639.113,092,698.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-01-21Versant Venture Capital VI, L.P.10% Share HolderSell8,091.0021.78176,221.983,110,547.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-01-17Versant Venture Capital VI, L.P.10% Share HolderSell11,103.0020.09223,059.273,118,638.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-01-16Versant Venture Capital VI, L.P.10% Share HolderSell22,489.0019.72443,483.083,129,741.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-03-06Global Strategic Fund II L.P. venBio10% Share HolderSell1,800.0023.7942,830.823,150,019.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-03-05Global Strategic Fund II L.P. venBio10% Share HolderSell8,500.0023.53200,010.953,151,819.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-01-15Versant Venture Capital VI, L.P.10% Share HolderSell7,511.0019.73148,192.033,152,230.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-14Versant Venture Capital VI, L.P.10% Share HolderSell12,307.0020.00246,140.003,159,741.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-03-04Global Strategic Fund II L.P. venBio10% Share HolderSell35,650.0023.81848,765.903,160,319.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-01-13Versant Venture Capital VI, L.P.10% Share HolderSell83.0020.841,729.723,172,048.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-13Versant Venture Capital VI, L.P.10% Share HolderSell11,593.0020.16233,714.883,172,131.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-10Versant Venture Capital VI, L.P.10% Share HolderSell19,343.0020.10388,794.303,183,724.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-03-03Global Strategic Fund II L.P. venBio10% Share HolderSell6,401.0023.00147,198.683,195,969.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-03-02Global Strategic Fund II L.P. venBio10% Share HolderSell10,297.0023.06237,459.123,202,370.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-01-09Versant Venture Capital VI, L.P.10% Share HolderSell16,527.0020.21334,010.673,203,067.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-02-28Global Strategic Fund II L.P. venBio10% Share HolderSell5,100.0021.30108,652.443,212,667.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-01-08Versant Venture Capital VI, L.P.10% Share HolderSell22,368.0019.80442,886.403,219,594.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-02-10Global Strategic Fund II L.P. venBio10% Share HolderSell7,836.0027.08212,168.323,225,861.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-27Global Strategic Fund II L.P. venBio10% Share HolderSell1,781.0022.5440,143.743,227,767.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-02-26Global Strategic Fund II L.P. venBio10% Share HolderSell2,523.0022.4456,615.363,229,548.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-02-25Global Strategic Fund II L.P. venBio10% Share HolderSell1,600.0023.6737,876.003,232,071.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-02-12Global Strategic Fund II L.P. venBio10% Share HolderSell6.0027.14162.843,233,671.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-11Global Strategic Fund II L.P. venBio10% Share HolderSell2,184.0027.0559,068.033,233,677.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-06Global Strategic Fund II L.P. venBio10% Share HolderSell6,102.0027.03164,954.763,233,697.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000115/0001012975-20-000115-index.htm
2020-02-05Global Strategic Fund II L.P. venBio10% Share HolderSell28,608.0025.99743,547.673,239,799.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000113/0001012975-20-000113-index.htm
2020-01-07Versant Venture Capital VI, L.P.10% Share HolderSell14,162.0020.05283,948.103,241,962.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-01-06Versant Venture Capital VI, L.P.10% Share HolderSell42,323.0019.93843,497.393,256,124.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-02-04Global Strategic Fund II L.P. venBio10% Share HolderSell53,731.0025.651,378,178.663,268,407.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000113/0001012975-20-000113-index.htm
2020-01-06Versant Venture Capital VI, L.P.10% Share HolderSell6,101.0018.32111,770.323,298,447.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-06Versant Venture Capital VI, L.P.10% Share HolderSell4,968.0017.6887,834.243,304,548.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-03Versant Venture Capital VI, L.P.10% Share HolderSell100.0020.272,027.003,309,516.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-03Versant Venture Capital VI, L.P.10% Share HolderSell3,100.0019.1859,458.003,309,616.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-13Global Strategic Fund II L.P. venBio10% Share HolderSell494,000.0020.239,993,620.003,322,138.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000033/0001012975-20-000033-index.htm
2020-01-08Global Strategic Fund II L.P. venBio10% Share HolderSell15,677.0019.86311,354.633,816,138.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000029/0001012975-20-000029-index.htm
2020-01-07Global Strategic Fund II L.P. venBio10% Share HolderSell31,000.0020.17625,149.103,831,815.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000022/0001012975-20-000022-index.htm
2020-01-06Global Strategic Fund II L.P. venBio10% Share HolderSell42,221.0019.64829,380.883,862,815.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000022/0001012975-20-000022-index.htm
2020-01-03Global Strategic Fund II L.P. venBio10% Share HolderSell12,498.0019.30241,213.903,905,036.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000013/0001012975-20-000013-index.htm
2020-01-02Global Strategic Fund II L.P. venBio10% Share HolderSell23,000.0019.94458,507.303,917,534.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000013/0001012975-20-000013-index.htm
2020-01-02Versant Venture Capital VI, L.P.10% Share HolderSell1,000.0022.1722,170.003,996,859.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-02Versant Venture Capital VI, L.P.10% Share HolderSell3,900.0021.2082,680.003,997,859.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-02Versant Venture Capital VI, L.P.10% Share HolderSell10,952.0019.89217,835.284,001,759.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-07-10Apple Tree Partners IV, L.P.10% Share HolderBuy415,000.0036.0014,940,000.005,830,203.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920083455/0001104659-20-083455-index.htm
2020-07-10Seth Loring HarrisonDirectorBuy415,000.0036.0014,940,000.005,830,203.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920083453/0001104659-20-083453-index.htm